These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children. Eichler I, Soriano ES. Allergy; 2011 Aug; 66(8):999-1004. PubMed ID: 21426358 [Abstract] [Full Text] [Related]
8. Patient-reported outcomes and quality-of-life questionnaires in the assessment of rhinoconjunctivitis in childhood. Larenas-Linnemann D, Pfaar O. Curr Opin Allergy Clin Immunol; 2014 Jun; 14(3):192-9. PubMed ID: 24781917 [Abstract] [Full Text] [Related]
9. Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis. Pfaar O, Klimek L, Gerth van Wijk R. Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):197-203. PubMed ID: 25899694 [Abstract] [Full Text] [Related]
10. [Allergens for specific immunotherapy: authorization and quality criteria of the Paul-Ehrlich-Institut]. May S, Kaul S, Schröder C, Vieths S. Hautarzt; 2006 Oct; 57(10):867-74. PubMed ID: 16977441 [Abstract] [Full Text] [Related]
12. New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs). Klimek L, Pfaar O, Worm M. Expert Rev Clin Immunol; 2016 Oct; 12(10):1123-35. PubMed ID: 27191353 [Abstract] [Full Text] [Related]
13. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation]. Kleine-Tebbe J, Ackermann-Simon J, Hanf G. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847 [Abstract] [Full Text] [Related]
14. Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation - summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019. Mahler V, Mentzer D, Bonertz A, Muraro A, Eigenmann P, Bousquet J, Halken S, Pfaar O, Jutel M, Wahn U, Vieths S, Kaul S. Clin Transl Allergy; 2020 Mar; 10():28. PubMed ID: 32612805 [Abstract] [Full Text] [Related]
15. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis. Serrano E, Wahn HU, Didier A, Bachert C. Am J Rhinol Allergy; 2014 Mar; 28(6):471-6. PubMed ID: 25335122 [Abstract] [Full Text] [Related]
19. The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook. Pajno GB, Nadeau KC, Passalacqua G, Caminiti L, Hobson B, Jay DC, Arasi S, Chiera F, Salzano G. Expert Rev Clin Immunol; 2015 Jan; 11(1):141-54. PubMed ID: 25454510 [Abstract] [Full Text] [Related]
20. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation. Tomasi PA, Egger GF, Pallidis C, Saint-Raymond A. Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869 [Abstract] [Full Text] [Related] Page: [Next] [New Search]